Added Value of Viscoelasticity for MRI-Based Prediction of Ki-67 Expression of Hepatocellular Carcinoma Using a Deep Learning Combined Radiomics (DLCR) Model
Overview
Authors
Affiliations
This study aimed to explore the added value of viscoelasticity measured by magnetic resonance elastography (MRE) in the prediction of Ki-67 expression in hepatocellular carcinoma (HCC) using a deep learning combined radiomics (DLCR) model. This retrospective study included 108 histopathology-proven HCC patients (93 males; age, 59.6 ± 11.0 years) who underwent preoperative MRI and MR elastography. They were divided into training ( = 87; 61.0 ± 9.8 years) and testing ( = 21; 60.6 ± 10.1 years) cohorts. An independent validation cohort including 43 patients (60.1 ± 11.3 years) was included for testing. A DLCR model was proposed to predict the expression of Ki-67 with cMRI, including T2W, DW, and dynamic contrast enhancement (DCE) images as inputs. The images of the shear wave speed (-map) and phase angle (-map) derived from MRE were also fed into the DLCR model. The Ki-67 expression was classified into low and high groups with a threshold of 20%. Both and values were ranked within the top six features for Ki-67 prediction with random forest selection, which revealed the value of MRE-based viscosity for the assessment of tumor proliferation status in HCC. When comparing the six CNN models, Xception showed the best performance for classifying the Ki-67 expression, with an AUC of 0.80 ± 0.03 (CI: 0.79-0.81) and accuracy of 0.77 ± 0.04 (CI: 0.76-0.78) when cMRI were fed into the model. The model with all modalities (MRE, AFP, and cMRI) as inputs achieved the highest AUC of 0.90 ± 0.03 (CI: 0.89-0.91) in the validation cohort. The same finding was observed in the independent testing cohort, with an AUC of 0.83 ± 0.03 (CI: 0.82-0.84). The shear wave speed and phase angle improved the performance of the DLCR model significantly for Ki-67 prediction, suggesting that MRE-based and -maps can serve as important parameters to assess the tumor proliferation status in HCC.
Imaging-Based Prediction of Ki-67 Expression in Hepatocellular Carcinoma: A Retrospective Study.
Cai C, Wang L, Tao L, Zhu H, Ren Y, Li D Cancer Med. 2025; 14(4):e70562.
PMID: 39964132 PMC: 11834164. DOI: 10.1002/cam4.70562.
Yin Y, Zhang W, Chen Y, Zhang Y, Shen X Heliyon. 2024; 10(23):e40588.
PMID: 39660185 PMC: 11629216. DOI: 10.1016/j.heliyon.2024.e40588.
Artificial intelligence techniques in liver cancer.
Wang L, Fatemi M, Alizad A Front Oncol. 2024; 14:1415859.
PMID: 39290245 PMC: 11405163. DOI: 10.3389/fonc.2024.1415859.
Kuang F, Gao Y, Zhou Q, Lu C, Lin Q, Al Mamun A J Hepatocell Carcinoma. 2024; 11:1445-1457.
PMID: 39050810 PMC: 11268741. DOI: 10.2147/JHC.S464916.
Fat fraction quantification with MRI estimates tumor proliferation of hepatocellular carcinoma.
Huang M, Zhang F, Li Z, Luo Y, Li J, Wang Z Front Oncol. 2024; 14:1367907.
PMID: 38665944 PMC: 11044697. DOI: 10.3389/fonc.2024.1367907.